| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |